SCHD puts dividend investors at critical crossroads

The income trade that beat the S&P 500 by double digits in 2026 just hit a new hurdle that could change what shareholders earn.

The 10-year Treasury yield topped 5% on Sept. 15, 2026, for the first time since 2007, marking a milestone last briefly touched intraday in October 2023 and sending shockwaves through dividend-paying stocks across the market, The Motley Fool reported.

The Schwab U.S. Dividend Equity ETF (SCHD) has dropped roughly 5.7% from its August 2026 record of $35, settling near $33 as bond yields surge, Benzinga showed. 

The fund holds roughly $100 billion in net assets and ranks as America’s largest dividend-focused ETF, Schwab data confirmed.

Despite the sell-off, net inflows into the fund have topped $18.2 billion over the past six months alone, TipRanks data showed. The gap between falling prices and rising demand has left income investors weighing whether the pullback marks a buying opportunity or the start of a deeper repricing.

Also Read: Jack Bogle’s 12-word investment rule fuels a trillion-dollar shift

Treasury yields above 5% squeeze SCHD from its record high

The Federal Reserve raised its benchmark rate by 25 basis points in September 2026, the first increase since 2023, and longer-duration yields have climbed sharply, CNBC reported.

Fewer than 4% of S&P 500 companies now offer a dividend yield above the 10-year Treasury rate, according to Ned Davis Research data shared by Schwab chief investment strategist Liz Ann Sonders.

The decline has not been isolated to SCHD, as the broader dividend-stock universe has felt the same gravitational pull from rising bond yields.

Ed Yardeni, president of Yardeni Research, warned that the yield’s breakout above 5% poses the most immediate danger to equity valuations across the board, Benzinga reported. 

Yardeni cut his year-end 2026 S&P 500 price target from 8,400 to 7,900, a roughly 6% reduction, citing higher-for-longer bond yields and rising downturn risks over the next three to six months.

Strong fundamentals give SCHD a case even as yields surge

Despite the competitive pressure from bonds, the fund’s underlying numbers tell a more nuanced story than the recent sell-off suggests. 

SCHD trades at a trailing price-to-earnings (P/E) ratio of about 17.87, below the S&P 500’s trailing P/E of roughly 26.37, GuruFocus noted, giving the fund a meaningful valuation discount against the broader market.

More Exchange Traded Funds:

• How smart investors use ETFs to legally bypass IRS wash sale rules
• Veteran manager buys 2 ETFs as market shifts
• One dividend ETF makes $1,000 a month possible

Its March 2026 reconstitution added Abbott Laboratories (ABT), UnitedHealth Group, and Procter & Gamble, while cutting energy exposure by 8%.  

Healthcare and consumer staples now account for roughly 41% of the portfolio, anchoring the fund in sectors that tend to hold up during recessions.

Brian Paoli, associate manager and research analyst at Morningstar, described SCHD’s approach as “sensible, transparent, and defensive” in his April 25, 2026, review of the fund.

The fund holds no exposure to Nvidia, Microsoft, or Apple, sidestepping the tech concentration risk that market voices, including Bridgewater founder Ray Dalio, have publicly flagged.

Technical indicators near $32 suggest a potential floor

The Relative Strength Index for SCHD has fallen to 28 over the past 10 days, crossing below the oversold threshold of 30, ETF Database data showed.

A critical support level near $32 aligns with the Murrey Math Lines pivot point that has marked prior turning points, Benzinga’s analysis indicated.

A hold above that level would signal the decline is a temporary pullback, with $34 as the next meaningful resistance target.

How SCHD’s dividend growth record compares to fixed Treasury yields

The technical case points to a floor near $32, but the decision for income investors hinges on what each option pays over time.

A 5% government bond yield comes with a guarantee, and the payout stays locked at purchase with no protection against inflation eroding its value.

SCHD’s income stream has grown in each of the past 14 consecutive years, a record no fixed-rate bond can match over that horizon, the Motley Fool reported. 

That compounding advantage has driven the fund to a total return above 61% over five years, a pace that bonds have not matched, Schwab performance data confirmed.

Across the broader market, dividends have supplied a meaningful share of gains as well, accounting for roughly 3.2 percentage points of the S&P 500’s 10.7% annualized total return over the same stretch.

Michael Clarfeld, managing director and portfolio manager at ClearBridge Investments, told InvestmentNews that dividend growth, total return, and risk all matter alongside the current yield when evaluating a dividend payer.

<strong>Beyond the headline or current yield, investors should look for dividend growth, as well as total return potential and risk</strong>.

SCHD charges an expense ratio of 0.06%, a cost that barely registers next to most actively managed income strategies, Schwab Asset Management confirmed.

Where the $32 support line leaves your income strategy

Yardeni’s warning about bond-yield headwinds and Clarfeld’s case for dividend growth over headline yield frame both sides of the decision that shareholders face. 

The tension between rising bond yields and the fund’s compounding dividend advantage defines the near-term risk profile for shareholders.

The fund’s valuation discount, record inflows, and oversold technical readings all suggest the retreat is more likely to stabilize than extend further, Benzinga’s analysis indicated. 

A sustained hold above $32 would confirm the pullback as a temporary dip and take the deeper repricing scenario off the table.

The trajectory of the 10-year yield remains the unresolved variable, because a sustained climb above 5% would extend the drag on income-generating equities broadly. 

The Federal Reserve’s next rate decision and incoming inflation data are the two catalysts most likely to determine the outcome, Benzinga’s analysis concluded.

Related: SCHD investors sit on a $216,000 gap no statement shows